Royal Bank of Canada’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,402
| Closed | -$185K | – | 6461 |
|
|
2024
Q3 | $185K | Sell |
6,402
-18,731
| -75% | -$541K | ﹤0.01% | 4436 |
|
|
2024
Q2 | $685K | Buy |
25,133
+20,907
| +495% | +$570K | ﹤0.01% | 3417 |
|
|
2024
Q1 | $118K | Sell |
4,226
-17,905
| -81% | -$500K | ﹤0.01% | 4653 |
|
|
2023
Q4 | $589K | Sell |
22,131
-24
| -0.1% | -$639 | ﹤0.01% | 3634 |
|
|
2023
Q3 | $566K | Buy |
22,155
+12,447
| +128% | +$318K | ﹤0.01% | 3480 |
|
|
2023
Q2 | $254K | Buy |
9,708
+530
| +6% | +$13.9K | ﹤0.01% | 4122 |
|
|
2023
Q1 | $240K | Sell |
9,178
-7,695
| -46% | -$201K | ﹤0.01% | 4103 |
|
|
2022
Q4 | $463K | Sell |
16,873
-25,543
| -60% | -$701K | ﹤0.01% | 3736 |
|
|
2022
Q3 | $1.02M | Buy |
+42,416
| New | +$1.02M | ﹤0.01% | 3014 |
|
|
2020
Q1 | – | Sell |
-400
| Closed | -$9K | – | 6190 |
|
|
2019
Q4 | $9K | Hold |
400
| – | – | ﹤0.01% | 5580 |
|
|
2019
Q3 | $8K | Hold |
400
| – | – | ﹤0.01% | 5212 |
|
|
2019
Q2 | $8K | Sell |
400
-2,600
| -87% | -$52K | ﹤0.01% | 5238 |
|
|
2019
Q1 | $64K | Sell |
3,000
-557
| -16% | -$11.9K | ﹤0.01% | 4402 |
|
|
2018
Q4 | $68K | Hold |
3,557
| – | – | ﹤0.01% | 4287 |
|
|
2018
Q3 | $84K | Buy |
3,557
+2,600
| +272% | +$61.4K | ﹤0.01% | 4356 |
|
|
2018
Q2 | $21K | Buy |
957
+400
| +72% | +$8.78K | ﹤0.01% | 4929 |
|
|
2018
Q1 | $12K | Hold |
557
| – | – | ﹤0.01% | 5038 |
|
|
2017
Q4 | $12K | Hold |
557
| – | – | ﹤0.01% | 5045 |
|
|
2017
Q3 | $11K | Hold |
557
| – | – | ﹤0.01% | 5473 |
|
|
2017
Q2 | $12K | Hold |
557
| – | – | ﹤0.01% | 4982 |
|
|
2017
Q1 | $11K | Sell |
557
-551
| -50% | -$10.9K | ﹤0.01% | 5240 |
|
|
2016
Q4 | $20K | Buy |
+1,108
| New | +$20K | ﹤0.01% | 5000 |
|